Quest Diagnostics (DGX) earnings Q2 2020


People volunteer for Covid-19 surveillance testing using the Quest Diagnostics self administered PCR test in Livingston, Montana.

William Campbell | Getty Images

Quest Diagnostics reported preliminary second-quarter revenue above analysts’ estimates on Monday, largely on growing demand for its Covid-19 testing services, sending its shares up 2.7% before the bell.

The company said revenue fell 6% to about $1.83 billion, but was still ahead of the average analyst estimate of $1.52 billion, according to Refinitiv I/B/E/S data.

Quest said results also reflected stronger-than-expected recovery in base testing volumes, which have fallen about 34% compared with year-ago period, excluding COVID-19 molecular and antibody testing.

The company had started witnessing a faster-than-expected recovery in its testing volumes in the United States in June, after a more than 40% decline during the last two weeks of March.

Excluding items, the diagnostics company is expecting to earn between $1.39 and $1.42 per share. Analysts are expecting adjusted profit of 12 cents.

Quest is expected to report second-quarter results on July 23.

Source link

Products You May Like

Articles You May Like

Why Mark Cuban did 6-figure deal with Hopscotch app
NFT ‘pricing will settle down’ over time
Will I need proof of vaccine to travel abroad?
Jeff Bezos would pay over $5 billion a year under Warren’s wealth tax
Elizabeth Warren, Bernie Sanders propose 3% wealth tax on billionaires

Leave a Reply

Your email address will not be published. Required fields are marked *